FDA Terminates COVID-19 Emergency Use Authorization Declaration for Drugs and Biological Products

The U.S. Department of Health and Human Services (HHS) Secretary has terminated the declaration authorizing the emergency use of drugs and biological products during the COVID-19 pandemic, effective June 29, 2027. This decision reflects the availability of FDA-approved therapeutic options for all ages and disease spectrums, reinforcing the temporary and targeted nature of emergency authorities.